Reference
Downing NS, et al. Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010. Journal of the American Medical Association 317: 1854-1863, No. 18, 9 May 2017. Available from: URL: http://dx.doi.org/10.1001/jama.2017.5150
Rights and permissions
About this article
Cite this article
Postmarket safety events common after FDA approval. Reactions Weekly 1652, 11 (2017). https://doi.org/10.1007/s40278-017-30148-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-30148-6